| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |